Msn 571 Pharmacology Final Exam
MSN 571 PHARMACOLOGY FINAL EXAM 1) A 40-year old female patient is being followed up for diabetes mellitus. She is currently onMetformin 1 gram twice a day and has been tolerating it well for about six months. Her hemoglobin A1c a week ago was 8.9%. The plan is to initiate liraglutide therapy in addition to the metformin. Which of the following statements is true with regards to liraglutide. Liraglutide may be stored in the refrigerator or freezer prior to first use. The brand name is Bydureon Nausea and/or vomiting are common side effects of therapy It should be administered intramuscularly into the upper arm. 2) The patient who takes insulin has just been prescribed a beta blocker drug. You recognize thatthe interaction of the beta blocker and the insulin may have which result? Decreased activity of the beta blocker drug Enhanced activity of the beta blocker drug Masked signs of hypoglycemia Masked signs of hyperglycemia 3) Which classification of oral hypoglycemic drugs decreases hepatic glucose production andincreases insulin sensitivity and peripheral glucose uptake? Sulfonylureas (glyburide) Meglitinides (glinides) Biguanide (metformin) alpha-glycosidase inhibitor (miglitol)
Información del documento
- Subido en
- 5 de febrero de 2024
- Número de páginas
- 9
- Escrito en
- 2023/2024
- Tipo
- Examen
- Contiene
- Preguntas y respuestas
